FERMENTALG EO -04
Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw mat… Read more
Market Cap & Net Worth: FERMENTALG EO -04 (1F6)
FERMENTALG EO -04 (F:1F6) has a market capitalization of $44.35 Million (€43.21 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #23842 globally and #2601 in its home market, demonstrating a 11.94% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying FERMENTALG EO -04's stock price €0.45 by its total outstanding shares 96024432 (96.02 Million).
FERMENTALG EO -04 Market Cap History: 2015 to 2026
FERMENTALG EO -04's market capitalization history from 2015 to 2026. Data shows change from $572.71 Million to $44.35 Million (-21.95% CAGR).
FERMENTALG EO -04 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how FERMENTALG EO -04's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 1F6 by Market Capitalization
Companies near FERMENTALG EO -04 in the global market cap rankings as of March 19, 2026.
Key companies related to FERMENTALG EO -04 by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
FERMENTALG EO -04 Historical Marketcap From 2015 to 2026
Between 2015 and today, FERMENTALG EO -04's market cap moved from $572.71 Million to $ 44.35 Million, with a yearly change of -21.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €44.35 Million | +4.65% |
| 2025 | €42.38 Million | +34.80% |
| 2024 | €31.44 Million | +10.57% |
| 2023 | €28.44 Million | -80.81% |
| 2022 | €148.15 Million | -48.96% |
| 2021 | €290.28 Million | +107.69% |
| 2020 | €139.77 Million | -8.40% |
| 2019 | €152.58 Million | -36.82% |
| 2018 | €241.49 Million | -21.25% |
| 2017 | €306.64 Million | +6.32% |
| 2016 | €288.43 Million | -49.64% |
| 2015 | €572.71 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of FERMENTALG EO -04 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $44.35 Million USD |
| MoneyControl | $44.35 Million USD |
| MarketWatch | $44.35 Million USD |
| marketcap.company | $44.35 Million USD |
| Reuters | $44.35 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.